Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Pharmaceutics & Drug Delivery ResearchISSN: 2325-9604
Hiromichi Gotoh Author
Subjects of specialization
Affiliation
Anti-HDV antibodies;
Hiromichi Gotoh, Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo
Biography
My name is Hiromichi Gotoh, Division of Nephrology, I am from Department of Internal Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo My area of interests are Anti-HDV antibodies;
Publications
Research Article Open Access
Sitagliptin Inhibits the Lipopolysaccharide-Induced Inflammation
Author(s): Hitomi Hasegawa, Yuya Nakamura, Mayumi Tsuji, Ran Ono, Tatsunori Oguchi, Katsuji Oguchi, Yuji Kiuchi, Isao Ohsawa, Hiromichi Gotoh, Yoshikazu Goto and Masahiro Inagaki
Sitagliptin Inhibits the Lipopolysaccharide-Induced Inflammation
Abstract
Objective: Sitagliptin is an anti-diabetic Dipeptidyl peptidase-4 (DPP-4) inhibitor; used worldwide with a well-established evidence base as an effective anti-diabetic therapy and the lowest cost of all DPP-4 inhibitors. Atherosclerosis and inflammation are more common in diabetic patients than in nondiabetic patients, and progression of atherosclerosis contributes to this infla... view more»
Google Scholars / Researchers Sites
